In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

Details of the new rules for COVID-19 vaccine approvals were also outlined in an article published by The New England Journal ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Only adults 65 and older or people with another health problem that puts them at higher risk will be able to get the shots ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...